LIU Zhi-jun@Institute of Material Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China Beijing Hospital of the Ministry of Health,Beijing 100050,China--ZHAO Ming@Institute of Material Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China--XUE Jian-fei@Institute of Material Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China--CHEN Nai-hong@Institute of Material Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China--;
ginsenosides Rb1; synapsin; PKA; CaMKⅡ; phosphorylation; fluorescent imaging system;
机译:人参皂苷Rb1通过调节依赖于cAMP的蛋白激酶途径的突触蛋白的磷酸化来促进神经递质的释放。
机译:人参皂苷Rg1和Rb1通过激活蛋白激酶C影响囊泡动员,从而增强了大鼠皮质神经末梢谷氨酸的胞吐作用。
机译:人参皂苷Rg1和Rb1通过激活大鼠大脑皮层神经末梢(突触小体)中的蛋白激酶A来增强谷氨酸的释放。
机译:CAMKⅡ可以由人参皂苷RB1激活,但不参与RB1增强的Synapsin磷酸化和谷氨酸脲糖尿e
机译:参与腺苷受体介导的泡沫细胞形成抑制的分子机制:A2A腺苷受体激活通过增强ABCA1和27-羟化酶依赖性胆固醇外排而减少泡沫细胞形成。
机译:SMYD2 RB1甲基化通过增加RB1磷酸化增强细胞周期进程
机译:20-O-β-D-吡喃葡萄糖基-20(S) - 人参皂甙RB1的代谢物,通过在人角质形成细胞中的SRC酪氨酸激酶介导的ERK和AKT激活来增强透明质酸的产生